Idiopathic generalized epilepsy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Particularly, we found rare microdeletions within or near two genes, RBFOX1 and NRXN1, previously shown to harbor deletions associated with idiopathic generalized epilepsy, and a microduplication in the proximal region of chromosome 1q21.1, where duplications have been associated with various neurodevelopmental disorders and epilepsy.
|
25243798 |
2014 |
Gilles de la Tourette syndrome
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Examination of available parents indicates that two out of three NRXN1 deletions detected in the TS cases are de-novo mutations.
|
23533600 |
2013 |
Idiopathic generalized epilepsy
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
We conclude that exon-disrupting deletions of NRXN1 represent a genetic risk factor in the genetically complex predisposition of common IGE syndromes.
|
23294455 |
2013 |
Impaired cognition
|
0.020 |
Biomarker
|
disease |
BEFREE |
Examples include CAPRIN1 and AFF2 (both linked to FMR1, which is involved in fragile X syndrome), VIP (involved in social-cognitive deficits), and other genes such as SCN2A and KCNQ2 (linked to epilepsy), NRXN1, and CHD7, which causes ASD-associated CHARGE syndrome.
|
23849776 |
2013 |
Dysmorphic features
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Generally, most individuals with NRXN1 exonic deletions have developmental delay (particularly speech), abnormal behaviors, and mild dysmorphic features.
|
23495017 |
2013 |
Congenital Abnormality
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Congenital malformations and dysmorphic features appeared infrequently and inconsistently among this population of patients with NRXN1 deletions.
|
22617343 |
2012 |
Dysmorphic features
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Congenital malformations and dysmorphic features appeared infrequently and inconsistently among this population of patients with NRXN1 deletions.
|
22617343 |
2012 |
Specific language impairment
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
Disruption of a number of these genes (including NRXN1, CNTNAP2 and CASK) are known to cause diverse neurodevelopmental brain disorder phenotypes including schizophenia, autism, learning disability and specific language disorder.
|
20574149 |
2011 |
Specific language impairment
|
0.020 |
Biomarker
|
disease |
BEFREE |
At a gene level, CAM genes associated in all three samples (NRXN1 and CNTNAP2), which were previously implicated in specific language disorder, autism and schizophrenia.
|
20157312 |
2011 |
Depressed mood
|
0.020 |
Biomarker
|
phenotype |
BEFREE |
Our data support previous observations that NRXN1 may be pathogenic in a wide variety of psychiatric diseases, including autism spectrum disorder, global developmental delay, anxiety, and depression.
|
20162629 |
2010 |
Mental disorders
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The two deletions upstream of the NRXN1 gene were found to segregate with psychiatric disorders in the family and further similar deletions have been observed in patients diagnosed with autism spectrum disorder.
|
26563496 |
2015 |
Abnormal behavior
|
0.030 |
GeneticVariation
|
phenotype |
BEFREE |
The two deletions upstream of the NRXN1 gene were found to segregate with psychiatric disorders in the family and further similar deletions have been observed in patients diagnosed with autism spectrum disorder.
|
26563496 |
2015 |
Mental disorders
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The observations suggest a possible gene-dose effect of NRXN1 mutations on type and severity of mental illness and support the notion that the penetrance and pleiotropy of pathogenic CNVs in general are determined by additional genetic variants in the genome.
|
22337556 |
2012 |
Mental Retardation
|
0.030 |
AlteredExpression
|
disease |
BEFREE |
Mutations affecting synaptic levels of neurexin-1β in autism and mental retardation.
|
22504536 |
2012 |
Mental disorders
|
0.030 |
GeneticVariation
|
group |
BEFREE |
The breakpoint at 2p was within the NRXN1 gene that has previously been associated with autism, intellectual disabilities, and psychiatric disorders.
|
21739571 |
2011 |
Abnormal behavior
|
0.030 |
GeneticVariation
|
phenotype |
BEFREE |
The breakpoint at 2p was within the NRXN1 gene that has previously been associated with autism, intellectual disabilities, and psychiatric disorders.
|
21739571 |
2011 |
Abnormal behavior
|
0.030 |
AlteredExpression
|
phenotype |
BEFREE |
NRXN1 is highly expressed in brain and has been shown recently to be associated with ASD, schizophrenia, cognitive and behavioral abnormalities, and alcohol and nicotine dependence.
|
20162629 |
2010 |
Mental Retardation
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
Mutations in NLGN3/4, SHANK3, or NRXN1 alter synaptic function and lead to mental retardation, typical autism, or Asperger syndrome.
|
19545994 |
2009 |
Mental Retardation
|
0.030 |
GeneticVariation
|
disease |
BEFREE |
CNTNAP2 and NRXN1 are mutated in autosomal-recessive Pitt-Hopkins-like mental retardation and determine the level of a common synaptic protein in Drosophila.
|
19896112 |
2009 |
Developmental delay (disorder)
|
0.060 |
GeneticVariation
|
phenotype |
BEFREE |
NRXN1 copy number variation is a rare genetic factor commonly shared among autism spectrum disorder (ASD), schizophrenia, intellectual disability, epilepsy and developmental delay.
|
31759289 |
2019 |
Global developmental delay
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
NRXN1 copy number variation is a rare genetic factor commonly shared among autism spectrum disorder (ASD), schizophrenia, intellectual disability, epilepsy and developmental delay.
|
31759289 |
2019 |
Developmental delay (disorder)
|
0.060 |
GeneticVariation
|
phenotype |
BEFREE |
We identified 41 (0.21%) previously unreported exonic NRXN1 deletions ascertained for developmental delay/intellectual disability that were significantly greater than in controls (odds ratio (OR) = 8.14; 95% confidence interval (CI): 2.91-22.72; P < 0.0001).
|
27195815 |
2017 |
Global developmental delay
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
We identified 41 (0.21%) previously unreported exonic NRXN1 deletions ascertained for developmental delay/intellectual disability that were significantly greater than in controls (odds ratio (OR) = 8.14; 95% confidence interval (CI): 2.91-22.72; P < 0.0001).
|
27195815 |
2017 |
Developmental delay (disorder)
|
0.060 |
GeneticVariation
|
phenotype |
BEFREE |
The intragenic NRXN1 deletion is thought to explain his developmental delay via a separate genetic mechanism.
|
26590955 |
2016 |
Global developmental delay
|
0.060 |
GeneticVariation
|
disease |
BEFREE |
The intragenic NRXN1 deletion is thought to explain his developmental delay via a separate genetic mechanism.
|
26590955 |
2016 |